Skip to main content
. 2017 Sep 1;96(35):e7920. doi: 10.1097/MD.0000000000007920

Figure 1.

Figure 1

Kaplan–Meier estimates of progression-free survival according to different treatment groups. The elderly patients in the CRT group had a significantly longer median progression-free survival than that in the RT group, 15.3 versus 10.6 months, P = .008. CRT = chemoradiotherapy, RT = radiotherapy.